Alap: ISHGIH
iShares Genomics Immunology and Healthcare ETF (Dist) | |
US46435U1925 | |
11.06.2019 | |
Equity | |
Részvény Sectors - Health Care | |
BlackRock iShares | |
BlackRock Fund Advisors | |
USD | |
1 000 | |
5% |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | -2.93% | -1.88% | 4.76% | 8.38% | -2.85% | -20.59% | -0.84% | - | - | N/A | |
Priemerná výkonnosť (36 meraní) | -1.60% | -16.20% | - | - | - | ||||||
Volatilita od priemernej výkonnosti | 12.21% | 40.99% | - | - | - |
Long | Short | Net | |
---|---|---|---|
Részvény | 99.63% | 99.63% | |
Kötvény | |||
Other | |||
Pénz piac | 0.60% | 0.24% | 0.37% |
Aktíva | 1 320 mil. |
Počet akcíí | 49 |
Počet dlhopisov | 0 |
Priebež. popl. | |
z toho Mng. popl. | 0.47 |
Výk. prémia | |
Trans. popl. |
Dividenda | 0.240 |
Dividendový výnos | 1.02% |
Rozhodný dátum | 20.12.2023 |
Frekvencia výplaty | polročne |
Giant | 19.15% |
Large | 17.07% |
Medium | 17.70% |
Small | 20.33% |
Micro | 25.39% |
P/E | 17.68% |
P/BV | 2.64% |
Healthcare | 99.63% |
Derivatives | 0.37 |
Výnos do splatnosti p.a. | |
Modifikovaná durácia |
United States | 69.94% |
Canada | 0.88% |
Latin America | |
United Kingdom | 4.37% |
Eurozone | 8.09% |
Europe - ex Euro | 7.61% |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | 4.52% |
Australasia | |
Asia - Developed | 0.99% |
Asia - Emerging | 3.23% |
Emerging Market | 3.23% |
Developed Country | 96.41% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
Moderna Inc | Healthcare | 5.85% | Revolution Medicines Inc Ordinary Shares | Healthcare | 5.65% |
Sarepta Therapeutics Inc | Healthcare | 5.47% | Merck & Co Inc | Healthcare | 4.46% |
GSK PLC | Healthcare | 4.37% | Regeneron Pharmaceuticals Inc | Healthcare | 4.24% |
Incyte Corp | Healthcare | 3.72% | Sanofi SA | Healthcare | 3.67% |
Exelixis Inc | Healthcare | 3.35% | Roche Holding AG | Healthcare | 3.35% |